Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Neoleukin Therapeutics, Inc. | Senior Vice President | Stock Option (Right to Buy) | 150K | Aug 2, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NLTX | Neoleukin Therapeutics, Inc. | Aug 2, 2022 | 1 | $0 | 4 | Aug 4, 2022 | Senior Vice President |
NLTX | Neoleukin Therapeutics, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 2, 2022 | Senior Vice President |
NLTX | Neoleukin Therapeutics, Inc. | Aug 3, 2021 | 1 | $0 | 4 | Aug 5, 2021 | Senior Vice President |
NLTX | Neoleukin Therapeutics, Inc. | Jun 16, 2021 | 1 | -$6.11K | 4 | Jun 17, 2021 | Senior Vice President |
NLTX | Neoleukin Therapeutics, Inc. | Jun 9, 2021 | 1 | -$7.04K | 4 | Jun 11, 2021 | Senior Vice President |
NLTX | Neoleukin Therapeutics, Inc. | Jun 8, 2021 | 1 | -$6.6K | 4 | Jun 9, 2021 | Senior Vice President |
NLTX | Neoleukin Therapeutics, Inc. | Jun 4, 2021 | 1 | -$6K | 4 | Jun 7, 2021 | Senior Vice President |
NLTX | Neoleukin Therapeutics, Inc. | May 26, 2021 | 1 | -$6K | 4 | May 26, 2021 | Senior Vice President |
NLTX | Neoleukin Therapeutics, Inc. | May 19, 2021 | 1 | -$6.38K | 4 | May 21, 2021 | Senior Vice President |
NLTX | Neoleukin Therapeutics, Inc. | May 12, 2021 | 1 | -$13.3K | 4 | May 12, 2021 | Senior Vice President |